메뉴 건너뛰기




Volumn 33, Issue 12, 2015, Pages 1414-1415

User beware: We need more science and less art when measuring financial toxicity in oncology

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; DISTRESS SYNDROME; FINANCIAL DEFICIT; HOUSEHOLD; HUMAN; INCOME; LETTER; ONCOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; SCIENCE; SOCIOLOGY; SUICIDE; WELLBEING; DOCTOR PATIENT RELATION; ECONOMICS; HEALTH CARE COST; NEOPLASMS;

EID: 84929493204     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.4986     Document Type: Letter
Times cited : (17)

References (8)
  • 1
    • 84907528059 scopus 로고    scopus 로고
    • Reporting and grading financial toxicity
    • Khera N: Reporting and grading financial toxicity. J Clin Oncol 32:3337-3338, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 3337-3338
    • Khera, N.1
  • 2
    • 51249133986 scopus 로고    scopus 로고
    • InCharge Financial Distress/Financial Well-Being Scale: Development, administration, and score interpretation
    • Prawitz AD, Garman ET, Sorhaindo B, et al: InCharge Financial Distress/Financial Well-Being Scale: Development, administration, and score interpretation. J Financl Couns Plann 17:34-50, 2006
    • (2006) J Financl Couns Plann , vol.17 , pp. 34-50
    • Prawitz, A.D.1    Garman, E.T.2    Sorhaindo, B.3
  • 3
    • 0042307310 scopus 로고    scopus 로고
    • Health care expenditure burdens among elderly adults: 1987 and 1996
    • Selden TM, Banthin JS: Health care expenditure burdens among elderly adults: 1987 and 1996. Med Care 41:III13-III23, 2003
    • (2003) Med Care , vol.41 , pp. III13-III23
    • Selden, T.M.1    Banthin, J.S.2
  • 5
    • 84929490046 scopus 로고    scopus 로고
    • Cancer patient kills himself day after he is told NHS Trust would not fund £25,000 drug
    • June 25
    • Camber R: Cancer patient kills himself day after he is told NHS Trust would not fund £25,000 drug. Daily Mail, June 25, 2008. http://www.dailymail.co.uk/news/article-1029038/Cancer-patient-kills-day-told-NHS-Trust-fund-25-000-drug.html#ixzz3FT52E6MI
    • (2008) Daily Mail
    • Camber, R.1
  • 6
    • 0027417437 scopus 로고
    • The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
    • Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993
    • (1993) J Natl Cancer Inst , vol.85 , pp. 365-376
    • Aaronson, N.K.1    Ahmedzai, S.2    Bergman, B.3
  • 7
    • 84908039974 scopus 로고    scopus 로고
    • The development of a financial toxicity patient-reported outcome in cancer: The COST measure
    • de Souza JA, Yap BJ, Hlubocky FJ, et al: The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer 120:3245-3253, 2014
    • (2014) Cancer , vol.120 , pp. 3245-3253
    • De Souza, J.A.1    Yap, B.J.2    Hlubocky, F.J.3
  • 8
    • 82955193739 scopus 로고    scopus 로고
    • Content validity: Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation-ISPOR PRO Good Research Practices Task Force report: Part 2. Assessing respondent understanding
    • Patrick DL, Burke LB, Gwaltney CJ, et al: Content validity: Establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation-ISPOR PRO Good Research Practices Task Force report: Part 2. Assessing respondent understanding. Value Health 14:978-988, 2011
    • (2011) Value Health , vol.14 , pp. 978-988
    • Patrick, D.L.1    Burke, L.B.2    Gwaltney, C.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.